Joinn Laboratories(China)Co.,Ltd.
SSE:603127.SS
19.8 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,018.334 | 2,376.487 | 2,267.971 | 1,516.68 | 1,075.905 | 639.379 | 408.798 | 301.279 | 241.805 | 206.606 | 184.815 | 143.829 | 97.389 |
| Cost of Revenue
| 1,444.56 | 1,394.934 | 1,181.66 | 777.558 | 523.092 | 302.818 | 192.051 | 131.756 | 119.793 | 100.132 | 86.512 | 71.291 | 49.825 |
| Gross Profit
| 573.774 | 981.553 | 1,086.311 | 739.122 | 552.813 | 336.562 | 216.748 | 169.523 | 122.012 | 106.474 | 98.303 | 72.538 | 47.564 |
| Gross Profit Ratio
| 0.284 | 0.413 | 0.479 | 0.487 | 0.514 | 0.526 | 0.53 | 0.563 | 0.505 | 0.515 | 0.532 | 0.504 | 0.488 |
| Reseach & Development Expenses
| 92.918 | 96.892 | 77.985 | 47.756 | 50.659 | 39.627 | 23.69 | 25.577 | 13.829 | 10.491 | 10.503 | 14.632 | 11.952 |
| General & Administrative Expenses
| 103.656 | 280.255 | 78.43 | 96.533 | 84.64 | 43.146 | 42.4 | 28.05 | 23.826 | 19.619 | 13.828 | 43.802 | 36.493 |
| Selling & Marketing Expenses
| 15.026 | 11.787 | 18.007 | 15.973 | 12.907 | 12.473 | 6.626 | 5.754 | 4.384 | 3.133 | 2.004 | 1.827 | 0.973 |
| SG&A
| 118.682 | 314.862 | 96.438 | 112.506 | 97.547 | 55.62 | 49.027 | 33.803 | 28.21 | 22.752 | 15.831 | 45.629 | 37.466 |
| Other Expenses
| 257.826 | 62.703 | 194.721 | 126.918 | 102.807 | 38.547 | 1.846 | -0.76 | 7.544 | 10.783 | 16.421 | 9.875 | 8.875 |
| Operating Expenses
| 469.426 | 474.457 | 369.143 | 287.18 | 251.013 | 133.794 | 101.091 | 77.166 | 68.585 | 58.434 | 46.984 | 46.984 | 40.898 |
| Operating Income
| 104.347 | 507.096 | 1,225.639 | 642.889 | 361.118 | 206.143 | 126.01 | 94.176 | 53.547 | 46.99 | 46.333 | 18.858 | -1.89 |
| Operating Income Ratio
| 0.052 | 0.213 | 0.54 | 0.424 | 0.336 | 0.322 | 0.308 | 0.313 | 0.221 | 0.227 | 0.251 | 0.131 | -0.019 |
| Total Other Income Expenses Net
| -0.308 | -0.146 | 14.363 | -0.885 | -0.546 | -0.253 | 1.846 | -0.76 | 7.463 | 10.694 | 16.193 | 7.506 | 0.297 |
| Income Before Tax
| 104.039 | 506.95 | 1,240.002 | 642.004 | 360.572 | 205.89 | 127.856 | 93.416 | 61.01 | 57.684 | 62.527 | 26.364 | 6.963 |
| Income Before Tax Ratio
| 0.052 | 0.213 | 0.547 | 0.423 | 0.335 | 0.322 | 0.313 | 0.31 | 0.252 | 0.279 | 0.338 | 0.183 | 0.071 |
| Income Tax Expense
| 34.284 | 115.398 | 166.802 | 85.587 | 46.944 | 27.678 | 19.669 | 16.97 | 9.317 | 8.509 | 13.529 | 4.076 | -2.663 |
| Net Income
| 74.075 | 396.993 | 1,074.257 | 557.46 | 315.014 | 178.373 | 108.338 | 76.446 | 51.692 | 49.174 | 48.996 | 22.288 | 9.626 |
| Net Income Ratio
| 0.037 | 0.167 | 0.474 | 0.368 | 0.293 | 0.279 | 0.265 | 0.254 | 0.214 | 0.238 | 0.265 | 0.155 | 0.099 |
| EPS
| 0.1 | 0.53 | 1.43 | 0.77 | 0.51 | 0.3 | 0.17 | 0.15 | 0.11 | 0.11 | 0.11 | 0.048 | 0.021 |
| EPS Diluted
| 0.1 | 0.53 | 1.43 | 0.77 | 0.51 | 0.3 | 0.17 | 0.15 | 0.11 | 0.11 | 0.11 | 0.048 | 0.021 |
| EBITDA
| 234.359 | 639.518 | 1,377.622 | 750.803 | 422.059 | 259.394 | 157.742 | 119.632 | 67.301 | 82.756 | 70.789 | 28.504 | 6.666 |
| EBITDA Ratio
| 0.116 | 0.269 | 0.607 | 0.495 | 0.392 | 0.406 | 0.386 | 0.397 | 0.278 | 0.401 | 0.383 | 0.198 | 0.068 |